Anti-Malaria Drug Policy - Ghana Health Service
Anti-Malaria Drug Policy - Ghana Health Service
Anti-Malaria Drug Policy - Ghana Health Service
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ANTI-MALARIA DRUG POLICY FOR GHANA<br />
4.2.1 Conditions for use of Sulphadoxine-<br />
Pyrimethamine<br />
All pregnant women shall undergo screening before the<br />
commencement of IPT in order to exclude those who are<br />
either G-6PD deficient or allergic to sulphonamides.<br />
Pregnant women who cannot take the Sulphadoxine-<br />
Pyrimethamine in IPT shall be encouraged to sleep under<br />
Insecticide Treated Nets and to report early when they have<br />
symptoms suggestive of malaria.<br />
4.3 Alternative <strong>Anti</strong>malarials to SP for Preventing<br />
<strong>Malaria</strong> in Pregnancy<br />
4.3.1 Pregnant women, especially those who are<br />
non-immune, may be put on Proguanil<br />
beginning in the first trimester of pregnancy<br />
5.0 MALARIA PROPHYLAXIS IN<br />
NON-IMMUNES<br />
Non-immune persons include:<br />
(a)<br />
(b)<br />
Persons living in non-malarious countries for six<br />
months or more<br />
Immmuno-compromised subjects<br />
MINISTRY OF HEALTH<br />
13
Change language